Showing results (111-120 of 204) with videos related to

Sort By:
Pageof 21
British Journal of Haematology|October 12, 2013
Transformed non-Hodgkin lymphoma in the rituximab era: analysis of the NCCN outcomes databaseMakiko Ban-Hoefen, Ann Vanderplas, Allison L Crosby-Thompson, et al.
Cancer|April 8, 2014
Comparison of referring and final pathology for patients with T-cell lymphoma in the National Comprehensive Cancer NetworkAlex F Herrera, Allison Crosby-Thompson, Jonathan W Friedberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 14, 2010
Time to treatment response in patients with follicular lymphoma treated with bortezomib is longer compared with other histologic subtypesOwen A O'Connor, Carol Portlock, Craig Moskowitz, et al.
Blood|October 17, 2015
A phase 2 study of idelalisib plus rituximab in treatment-naïve older patients with chronic lymphocytic leukemiaSusan M O'Brien, Nicole Lamanna, Thomas J Kipps, et al.
American Journal of Hematology|February 14, 2020
Urelumab alone or in combination with rituximab in patients with relapsed or refractory B-cell lymphomaJohn Timmerman, Charles Herbaux, Vincent Ribrag, et al.
Blood|February 2, 2018
A phase 1 study of ibrutinib in combination with R-ICE in patients with relapsed or primary refractory DLBCLCraig S Sauter, Matthew J Matasar, Heiko Schoder, et al.
British Journal of Haematology|January 21, 2010
High-dose chemo-radiotherapy for relapsed or refractory Hodgkin lymphoma and the significance of pre-transplant functional imagingCraig H Moskowitz, Joachim Yahalom, Andrew D Zelenetz, et al.
Blood Advances|January 26, 2021
Active surveillance of primary extranodal marginal zone lymphoma of bronchus-associated lymphoid tissueErel Joffe, Yan Leyfman, Esther Drill, et al.
Pageof 21